SYDNEY - Kazia Therapeutics Limited (NASDAQ: KZIA), a micro-cap biotech company with a market capitalization of $4.97 million specializing in oncology drug development, has received a research ...
Kazia Therapeutics (KZIA) announced a research grant awarded from The Michael J. Fox Foundation for Parkinson’s Research, MJFF, to fund research between The Hebrew University of Jerusalem and ...
SYDNEY - Kazia Therapeutics Limited (NASDAQ: KZIA), a micro-cap biotech company with a market capitalization of $4.97 million specializing in oncology drug development, has received a research grant ...
Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or "the Company"), an oncology-focused drug development company, today announced a research grant awarded from The Michael J. Fox Foundation for ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
After hours: 7:22:18 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results